MedPath

Clinical and immunological study of MERS-recovered patients more than 8 years after infectio

Not Applicable
Active, not recruiting
Conditions
Certain infectious and parasitic diseases
Registration Number
KCT0008575
Lead Sponsor
ational Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Active, not recruiting
Sex
All
Target Recruitment
35
Inclusion Criteria

MERS recovered patients

Exclusion Criteria

not applicable

Study & Design

Study Type
Observational Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Screening every 6 months and chest CT and pulmonary function tests every 12 months during the 8~9 year after MERS recovery, followed by result analysis
Secondary Outcome Measures
NameTimeMethod
Analysis of antibody dynamics in the blood of MERS-recovered patients;Investigation of T lymphocyte function in the blood of MERS-recovered patients
© Copyright 2025. All Rights Reserved by MedPath